Xenon

Veja o organograma con seus 20 executivos principais

Biografias mais buscadas da Xenon

• Ian Mortimer, President, Chief Executive Officer and Director
• Mohammad Azab, Director
• Steven Gannon, Director

Recentes movimentos de executivos em Xenon

• Justin Gover, ingressou na Companhia como Director  (Notícia publicada em 9 de agosto de 2023).
• Gillian Cannon, ingressou na Companhia como Director  (Notícia publicada em 9 de agosto de 2023).

Criar um alerta
para seguir os movimentos de executivos da Xenon.

Xenon possui 1.867 concorrentes concorrentes Pfizer (Estados Unidos), Sanofi (França) e Johnson & Johnson (Estados Unidos).

Popular M&A news in Farmacêutica

• AstraZeneca has announced the acquisition of Fusion Pharma  (publicado em 23 de março de 2024).
• AstraZeneca has announced the acquisition of Amolyt Pharma  (publicado em 19 de março de 2024).
• Frontier Medicines acaba de anunciar uma arrecadação de fundos de 80 milhões de dólares. (publicado em 27 de fevereiro de 2024).

Outros contatos sugeridos na indústria do Farmacêutica

• Jean-Frédéric Paulsen - Executive Chairman of the Board da Ferring Pharmaceuticals
• Alice Schardt-Rossmann - Managing Director da Dirk Rossmann
• Thierry Abribat - Chief Executive Officer da Amolyt Pharma

Saiba mais sobre a indústria do Farmacêutica >

Últimos comunicados de imprensa de Xenon

• Xenon Pharmaceuticals Provides Update on Partnered Program with Neurocrine Biosciences | Xenon Pharmaceuticals Inc.
• Xenon Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Corporate Update | Xenon Pharmaceuticals Inc.
• Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss Third Quarter 2023 Financial Results and Provide Corporate Update | Xenon Pharmaceuticals Inc.
• Xenon Pharmaceuticals to Present at TD Cowen’s 3rd Annual Novel Mechanisms in Neuropsychiatry Summit | Xenon Pharmaceuticals Inc.
• Xenon Pharmaceuticals Announces Publication of Results from XEN1101 Phase 2b “X-TOLE” Clinical Trial in Peer-Reviewed Journal Article in JAMA Neurology | Xenon Pharmaceuticals Inc.
• Xenon Pharmaceuticals to Present at Jefferies Inaugural Biotech CNS/Neuro Summit | Xenon Pharmaceuticals Inc.
• Xenon Pharmaceuticals Announces Upcoming Investor Webinar with Leading Key Opinion Leaders to Discuss XEN1101 and Major Depressive Disorder | Xenon Pharmaceuticals Inc.
• Xenon Pharmaceuticals Showcases XEN1101 Epilepsy Program at 35th International Epilepsy Congress | Xenon Pharmaceuticals Inc.
• Xenon Pharmaceuticals to Present at the Wells Fargo 2023 Healthcare Conference | Xenon Pharmaceuticals Inc.
• Xenon Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Corporate Update | Xenon Pharmaceuticals Inc.
• View more press releases Close

Redes sociais sobre Xenon

• Xenon na Wikipedia, Google News e Yahoo Finance
• Xenon na LinkedIn, Twitter e YouTube

Contate seus executivos por e-mail agora, incluindo Ian Mortimer

Ligue para a Xenon em +1 604...

Veja o organograma

Register to receive your alert

Relatório um erro